Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Acute Pancreatitis
NCT02885441Phase 4Terminated
- Sponsor
- Ilam University of Medical Sciences
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketorolac in acute pancreatitis (AP) (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoint: Change in C-Reactive Protein at 5 days. Started Sep 2016; status: terminated.
02
Drugs
ketorolac
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02885441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885441.